Dava Pharms Inc Company Profile
What is the competitive landscape for DAVA PHARMS INC
DAVA PHARMS INC has thirty-eight approved drugs.
Drugs and US Patents for Dava Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dava Pharms Inc | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 087451-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Dava Pharms Inc | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 075407-001 | Jan 28, 2000 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dava Pharms Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 071686-001 | Jan 5, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Dava Pharms Inc | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064116-001 | Apr 28, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Dava Pharms Inc | METHYLDOPA AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; methyldopa | TABLET;ORAL | 072507-001 | Jun 2, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Dava Pharms Inc | CAPTOPRIL | captopril | TABLET;ORAL | 074423-002 | Feb 13, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

